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To assess influenza vaccination coverage in Germany, we conducted a nationwide telephone survey in
November 1999 in adults (>18 yrs) using random-digit dialing. Overall, 23% of 1,190 survey participants
reported having been vaccinated (adjusted 18%) with 16% (adjusted 15%) in former West Germany ver-
sus 35% (adjusted 32%) in former East Germany. Immunization rates for vaccination target groups were
lower in West Germany (21%) than in East Germany (40%). Seven percent of health-care workers were
immunized. Previous influenza vaccination, positive attitudes towards immunization, and having a family
physician increased the rate of vaccination; fear of adverse effects lowered the rate. Family physicians
performed 93% of the vaccinations, which suggests their key role in improving low vaccination coverage in
Germany. The fact that >71% (850/1,190) of participants belonged to at least one of the vaccination target
groups recommended by the German Standing Commission on Immunization emphasizes the need to
focus the definition of target groups.
en years after the reunification of the former East and
West Germany, the Federal Republic of Germany still
shows the effects resulting from combining two different
health-care systems after being apart for 50 years. Even
though the health-care systems were merged soon after reuni-
fication, differences in health-care practices persist, especially
in regard to preventive medicine and immunization, which had
a much higher priority in the former East Germany. For exam-
ple, a pilot study undertaken in Berlin, Stuttgart, and Chemnitz
during the influenza season 1998–1999 showed much higher
influenza vaccination rates in East Berlin and Chemnitz in the
former East Germany (called former East in this paper) than in
West Berlin and Stuttgart in the former West Germany (called
former West in this paper) (1,2). 
In general, population-based studies of influenza vaccina-
tion coverage for a country do not exist. A Canadian study
found 13.8% influenza vaccination coverage in fall and winter
1990–1991 (3). Most studies on influenza vaccination cover-
age investigate specific groups such as the elderly (4–13),
patients from general practices (14,15), or hospitalized
patients (16).
This lack of nationwide, population-based studies, along
with the findings of the pilot study showing markedly different
vaccination rates in several German cities, prompted the
nationwide, population-based survey reported here. The goals
of our survey were to determine the influenza immunization
rates in areas of the former East and West during the 1999–
2000 influenza season, the proportion of the German popula-
tion included in specific vaccination target groups recom-
mended by the German Standing Commission on
Immunization, the vaccination rates among these target
groups, and factors that might influence immunization rates in
areas of the former East and West.
Methods
Background
Germany has a population of 82 million; 14 million live in
areas of the former East and 68 million in areas of the former
West (17). The German Standing Commission on Immuniza-
tion has recommended that the following groups receive influ-
enza vaccination: 1) persons >60 years old, 2) persons with
chronic illness, 3) health-care professionals, and 4) persons
who have extensive contact with the general public. The first
three groups comprise an estimated 35% of the general popu-
lation and 42% of the adult population of Germany (Arbeits-
gruppe Seuchenschutz, Robert Koch-Institut, 7 September
1999). The size of the fourth group is unclear because of its
widely applicable definition. For the target groups, the influ-
enza vaccination period started in September 1999. Vaccina-
tions were administered free of charge.
Survey
The target survey population included noninstitutionalized
persons >18 years of age living in Germany. A standardized,
pretested questionnaire was administered by telephone on
November 8 and November 22, 1999. Sample households
were chosen by random-digit dialing by using a computer-gen-
erated list of possible telephone numbers. Approximately half
of the telephone numbers on the list had prefixes in the former
East. However, the proportion of working phone numbers was
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lower in the former East, so the actual number of former East
residents who answered the phone and agreed to participate
was <50% of all participants. The person who initially
answered the telephone was eligible to be interviewed; to be
eligible, persons also had to be >18 years of age, live in a pri-
vate household, and have sufficient knowledge of German to
be able to understand and answer the questions. If persons <18
years of age answered the phone, they were asked if an adult
was present in the household, and an attempt was made to
interview that person. After verbal, informed consent was
obtained from the participant, we administered a questionnaire
that gathered information about demographics, individual risk
factors for contracting influenza, history of vaccination, gen-
eral attitude towards immunization, perceived efficacy and
adverse effects of the influenza vaccine, as well as other fac-
tors that might influence whether a person was likely to have
been vaccinated. 
Participants were counted as being vaccinated in the current
influenza season if they reported having received an influenza
vaccination after September 1, 1999. Persons were counted as
being in a target group recommended by the German Standing
Commission on Immunization if they reported one or more of
the following: 1) age of >60 years, 2) chronic illness currently
requiring regular medical supervision or treatment, 3) work in a
health-care environment, in which at least half the working day
involved interacting with patients, and 4) working at a job in
which more than half the working day was spent with people
who were not their colleagues. To provide added specificity,
these latter two groups were narrower in scope than those
defined by the Standing Commission on Immunization. In the
following text, these two groups are summarized as “profes-
sional exposure.” Immunization rates were adjusted for age,
sex, and residence in areas of the former East and West accord-
ing to the official 1998 population data (17). 
Results
Study Population
Dialing 4,863 numbers yielded 2,057 actual connections.
Of these, 25 were discarded because the person who answered
the phone had insufficient knowledge of German and 24
because no present household member was >18 years of age.
Of the remaining 2,008 persons, 1,190 (59%) participated in
the survey. Of the participants, 718 (60%) reported living in
the former West, 462 (39%) in the former East, and 10 (1%)
did not report location of residence. Sixty-three percent (452)
of survey participants living in the former West and 60% (276)
living in the former East were women. The median age was 47
years for persons living in the former West and 51 years for
those in the former East. Three percent (33) of survey partici-
pants were not German citizens. 
Immunization Status
Of the 1,183 participants who reported their vaccination
status, 277 (23%) reported having been vaccinated since Sep-
tember 1. Reported immunization rates were much lower in
the former West Germany (16%; 115/715) than in the former
East (35%; 159/459). The study population differed from the
general German population with regard to age structure, gen-
der, and place of residence in the former East or West as
reported in the official population data from 1998 (17). The
estimated immunization rate for the whole country, adjusted
for age, gender, and place of residence (former West or East),
was 18% (95% confidence interval [CI] 16% to 21%). The
age- and gender-adjusted immunization rate in the former
West was 15% (95% CI 13% to 18%), a figure significantly
lower than 32% (95% CI 28% to 37%) in the former East. 
Sixty-eight percent (489) and 78% (361) of survey respon-
dents living in the former West and East, respectively, reported
at least one characteristic that placed them in an influenza
immunization target group. Among target group members,
reported vaccination rates were nearly twice as high among
those living in areas of the former East (40%; 142/358) than
those living in areas of the former West (21%; 101/486).
Immunization rates were higher among all target subgroups in
areas of the former East (Table 1). Vaccination rates were par-
ticularly low among health-care workers (7% [95% CI 1% to
13%] in the former West and 10% [95% CI 1% to 19%] in the
former East). 
Possible Factors Influencing Immunization
We restricted our analyses of factors influencing the
immunization rate to those reported by the 587 participants in
the target subgroups (aged >60 years, chronically ill, and
 Table 1. Immunization rates in the target groups for influenza vaccination, former West and East Germany, November 1999
Target groups
Former West Germany Former East Germany
Vaccinated % (95% CIa) Total Vaccinated % (95% CIa)T o t a l
>60 yrs of age 78 37 (30% to 43%) 213 90 55 (47% to 63%) 163
Chronic illness 51 31 (24% to 39%) 164 81 49 (41% to 57%) 165
Professional exposure 21 9 (5% to 13%) 243 39 25 (19% to 33%) 155
Health-care workers 4 7 (2% to 16%) 60 2 10 (1% to 30%) 21
Workers with public contact 17 9 (6% to 14%) 183 37 28 (20% to 36%) 134
One or more of the above 101 21 (17% to 25%) 486 b 142 40 (35% to 45%) 358b
aCI, confidence interval.
bTotals do not include three persons from former West Germany and three persons from former East Germany for whom information on immunization status was not available.RESEARCH
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working in the health-care profession) and for whom informa-
tion on area of residence in former East or West, as well as
vaccination status, was available. Among these persons, those
reporting a positive overall attitude towards immunization,
those believing that the vaccine is efficacious, and those hav-
ing had received an influenza vaccination in previous years
were much more likely to have been vaccinated in the current
immunization period (Table 2). Those reporting fear of con-
tracting influenza from vaccination and fear of other adverse
effects had lower immunization rates. 
Participants who had read at least one media article in the
fall about influenza immunization or who thought influenza a
serious illness had similar or slightly higher immunization
rates than those without these characteristics (Table 2).
Although all the participants included in this analysis reported
at least one characteristic of the target subgroups, only 21%
(121/587) considered themselves to be at increased risk of
contracting influenza compared with the general public. 
Role of the Family Physician
Vaccinated survey participants in the key target vaccina-
tion groups (those aged >60 years, those with chronic illness,
and health-care professionals) reported that family physicians
performed 93% (84/90) and 94% (106/113) of vaccinations in
the former West and East, respectively. Among those partici-
pants not vaccinated, more than half (52% in the former West
and 63% in the former East) stated that they would have
agreed to be vaccinated on the advice of a physician. Persons
who reported having a regular family physician had higher
immunization rates (Table 2). Those who had visited a physi-
cian since September 1, 1999, were more likely to have been
immunized than those who had not. During the visit, if the
physician had advised immunization, the probability of being
immunized increased further. However, only 40% (94/233)
and 60% (118/196) of those living in the former West and
East, respectively, who reported having had a consultation
since September 1, 1999, also reported having been offered
influenza vaccination by their physician. 
Immunization in the Workplace
Of the working survey participants, 18% (70/386) and
15% (33/228) in the former West and East, respectively, indi-
cated that influenza immunization had been offered at the
workplace. For those employed in health-care professions,
Table 2. Factors significantly influencing likelihood of an influenza vaccination during the immunization period (1999–2000) for 587 survey partici-
pants, by area of residence, November 1999a–c 
Former West Germany Former East Germany
Vaccination
OR 95% CI
Vaccination
OR 95% CI Yes No Yes No
Influenza vaccination in previous years Yes 69 52 10.4 5.8% to 19.1% 101 42 18.4 8.9% to 40.9%
No 24 190 12 93
Positive attitude towards immunization in general Yes 78 164 7.8 1.9% to 68.9% 108 103 6.3 1.3% to 58.8%
No 2 33 2 12
Belief in efficacy of vaccine Yes 84 159 9.7 2.4% to 85.3% 111 94 12.3 2.9% to 110.9%
No 2 34 2 21
Belief that influenza is a severe disease Yes 73 200 3.1 0.7% to 28.3% 90 106 2.3 0.7% to 10.4%
No 2 17 4 11
Information from the media Yes 48 134 0.9 0.5% to 1.4% 80 77 1.8 1.0% to 3.2%
No 44 105 32 56
Regular family physician Yes 92 217 11.8 1.9% to 490.6% 112 123 5.0 1.1% to 47.2%
No 1 28 2 11
Consultation with physician since September 1, 1999 Yes 81 152 4.4 2.2% to 9.6% 109 87 14.6 5.1% to 57.9%
No 11 91 4 47
Vaccination offer during consultationd Yes 63 31 13.5 6.7% to 27.9% 83 35 4.7 2.5% to 9.2%
No 18 121 26 52
Fear of contracting influenza through vaccination Yes 17 111 0.2 0.1% to 0.5% 29 62 0.5 0.3% to 0.8%
No 55 84 60 59
Fear of adverse effects Yes 5 54 0.1 0.0% to 0.3% 11 24 0.3 0.1% to 0.7%
No 80 87 94 62
aOR, odds ratio; CI, confidence interval.
bDenominator varies because persons who indicated “don’t know” were not included in the analysis.
cTarget groups included those >60 years of age, the chronically ill, and those who worked as professionals in the health-care sector.
dOnly persons having seen a physician since September 1, 1999.Emerging Infectious Diseases  •  Vol. 8, No. 12, December 2002 1445
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these percentages were 35%  (21/60) and 43% (9/21) in the
former West and East, respectively. Five (6%) of the 80 immu-
nized working participants were immunized at the workplace.
Discussion
We estimate that, as of November 22, 1999, 18% of the
German population >18 years of age had received influenza
vaccination for the 1999–2000 influenza season. This percent-
age corresponds to the 20% maximum estimate of the immuni-
zation rate calculated from the number of vaccine doses sold
for the immunization period 1999–2000, assuming all doses
sold were given (13.1 million doses for the 1999 influenza
vaccination period; data provided by the suppliers). The esti-
mated immunization rate of 18% is substantially lower than
the target of 42%, based on percentage of the adult population
comprising the key target groups for vaccination. Vaccination
rates were nearly twice as high among persons living in the
former East than in the former West, despite the fact that the
two health-care systems have been unified for almost 10 years.
Similar geographic differences in rates existed among all rec-
ommended vaccination target groups. Nevertheless, vaccina-
tion rates were inadequate among the key target groups of the
elderly and those chronically ill in all areas; only approxi-
mately one third of persons in the former West and one half in
the former East were vaccinated. Another finding was the low
vaccination rates among surveyed health-care workers; how-
ever, few health-care workers were surveyed. 
In Germany, the attitudes and practices of the family physi-
cians may be a critical factor in influencing influenza vaccina-
tion rates. Our study showed that persons in key target groups
for vaccination (age >60 years, chronic illness, health-care
professionals) who had had a regular family physician and had
had a recent medical consultation during which the physician
offered vaccination were much more likely to have been vacci-
nated. These results are consistent with other studies showing
the importance of physicians or health-care personnel in moti-
vating people for influenza vaccination (3,9). Almost all vacci-
nations, both in the former West and East, were given by a
family physician, and over half the nonimmunized participants
stated they would have agreed to be vaccinated on advice of a
physician. Family physicians thus have a substantial opportu-
nity to improve immunization coverage by more actively and
frequently recommending vaccination, especially to persons
belonging to a risk group. The fact that 60% of participants
belonging to key target groups for influenza vaccination in the
former West and 40% in the former East who had seen their
physician during the immunization period were not actively
offered vaccination indicates many missed opportunities for
vaccination. A study by Booth et al. (14) shows that 71% to
82% of general practitioners reported having routinely offered
influenza vaccination to patients from risk groups. Although
similar data do not exist for Germany, that only 40% to 60% of
our survey participants reported having been offered immuni-
zation suggests that fewer general practices routinely offer
vaccination. Perenboom et al. (18) found that, in the Nether-
lands, when general practitioners invited their chronically ill
patients to be vaccinated, vaccination coverage increased
among this group to 75.5%, compared with 42% for the same
risk group found in the National Health Interview Survey. 
Health-care workers represent a specific target group with
an extremely low vaccination rate. Because the number of
health-care workers who participated in this study was low (81
workers), results must be carefully interpreted. Our results,
however, were confirmed by later studies (Hallauer et al.,
unpub. data; 6). Health-care workers might not be reached by
family physicians, but rather by alternative interventions such
as vaccination programs at the workplace. However, this group
needs further investigation regarding targeted interventions to
increase vaccination coverage. 
Among those in key target groups for vaccination, persons
who had received an influenza immunization in a previous
year were much more likely to have been immunized during
the current period. This conclusion is consistent with the find-
ings of several previous studies (19–28). Therefore, a con-
certed effort to increase vaccination coverage in target groups
in 1 year might have a positive impact on revaccination in the
following years. This success rate might be one reason for the
persistently higher vaccination rates among persons living in
the former East. 
Our results suggest several possibilities for improving
influenza vaccination rates in Germany. One possibility would
be to better focus the target populations for influenza vaccina-
tion. We found that approximately 70% of the population fit
into a target vaccination group, largely due to the category
comprising public exposure in the workplace. Despite the fact
that our definition for this target group (persons who spend
more than half their working day dealing with many people
not their colleagues) was narrower than that used by the Ger-
man Standing Commission on Immunization (public exposure
in the workplace), this group included almost half the partici-
pants belonging to target groups. Were this group defined
more precisely, the criteria could be communicated more
clearly to family physicians and employers and thus make the
indications for immunization less ambiguous.
Fear of contracting influenza through immunization and
fear of adverse effects had a negative impact on the immuniza-
tion rate, as seen in other studies (3,9,19,21,22,24,26,28,29–
33). Health information messages, particularly those given by
physicians aimed at reducing these fears, may have a benefi-
cial effect on vaccination rates. Earlier research suggests that
the self-perception of influenza risk is often inaccurate (1,2).
Our study confirms this finding; only about one fifth of those
participants belonging to a target group were, in their own
opinion, at higher risk of becoming more severely ill from
influenza than the general population. Again, we suggest that
targeted information about risk factors for influenza and com-
plications should be enforced. Another way to increase vacci-
nation rates may be to improve workplace immunization
programs, particularly for health-care workers. We found that
<40% of health-care workers interviewed in this studyRESEARCH
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reported having a workplace influenza immunization program.
With <10% of the health-care workers reporting having been
vaccinated, the existing programs must be largely ineffective. 
Our study has several limitations. The study population
differed from the general population in age, gender, and place
of residence. To avoid possible biases because of these differ-
ences, we used standardized figures. Influenza vaccination
was self-reported; because the survey was anonymous, confir-
mation of vaccination status was not possible. In addition,
because we were unable to repeatedly call households on dif-
ferent days if nobody answered the phone on the first try, per-
sons who spent more time at home were probably more likely
to participate, resulting in an overrepresentation of persons in
certain vaccination target groups (age >60 years, chronic ill-
ness). Persons who lived in households without telephones or
could not speak German were also not sampled. If these
groups have a lower vaccination rate, our estimated vaccina-
tion rate will then have been overestimated.
The timing of the survey (late November) may have led to
an underestimate of the true vaccination rate because partici-
pants might have been vaccinated later in the season. No stud-
ies from Germany on vaccine uptake during the vaccination
period have been available up to now. However, the overall
vaccination rate shows that the study (18%) and the vaccina-
tion rate calculated by using the number of doses sold (20%)
correspond closely and suggests that the number of persons
vaccinated in the later months of the immunization period was
low. Although the German influenza vaccination experience
reported in this study suggests areas for improvement, the cir-
cumstances resulting from the German reunification also dem-
onstrate the long-term benefits of a sustained, concerted effort
to improve influenza vaccination rates.
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